Heroux Devtek (TSE:HRX) had its price objective boosted by TD Securities from C$17.50 to C$19.50 in a report issued on Friday. The firm currently has a “buy” rating on the stock. TD Securities’ price target suggests a potential upside of 39.58% from the company’s previous close.
Other analysts have also issued reports about the stock. Royal Bank of Canada boosted their price objective on shares of Heroux Devtek from C$19.00 to C$20.00 in a report on Friday. Raymond James upgraded shares of Heroux Devtek from a “market perform” rating to an “outperform” rating and reduced their price objective for the company from C$17.00 to C$16.50 in a report on Tuesday, November 13th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of C$18.75.
Shares of TSE HRX traded down C$0.01 during trading on Friday, hitting C$13.97. 68,325 shares of the company were exchanged, compared to its average volume of 30,874. Heroux Devtek has a 12-month low of C$11.05 and a 12-month high of C$16.75. The company has a quick ratio of 2.52, a current ratio of 4.08 and a debt-to-equity ratio of 65.42. The firm has a market cap of $461.17 million and a PE ratio of 37.96.
Heroux Devtek Company Profile
Héroux-Devtek Inc engages in the design, development, manufacture, integration, testing, and repair and overhaul of aircraft landing gears, hydraulic flight control actuators, and fracture-critical components in Canada, the United States, and the United Kingdom. The company also manufactures and sells hydraulic systems, fluid filtration systems, electronic enclosures, heat exchangers, and cabinets for suppliers of airborne radar, electro-optic systems, and aircraft controls.
Read More: What is a blue-chip stock?
Receive News & Ratings for Heroux Devtek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heroux Devtek and related companies with MarketBeat.com's FREE daily email newsletter.